Abstract
Naringin was previously reported as a multifunctional agent. Recently, naringin was found to play a protective role in various inflammatory conditions. However, the role of naringin in cartilage degeneration and osteoarthritis (OA) progression is still unknown. TNF-α is reported to play a detrimental role in OA. Herein, primary murine chondrocytes were isolated and cultured with stimulation of TNF-α, in the presence or absence of naringin treatment. As a result, naringin attenuated TNF-α-mediated inflammation and catabolism in chondrocyte. Besides, surgically induced OA mice models were established. Cartilage degradation and OA severity were evaluated using Safranin-O staining, immunohistochemistry, and ELISA. Moreover, levels of inflammatory cytokines and catabolic markers in OA were analyzed. Oral administration of naringin alleviated degradation of cartilage matrix and protected against OA development in the surgically induced OA models. Furthermore, the protective function of naringin in cartilage and chondrocyte was possibly due to suppression of NF-κB signaling pathway. Collectively, this study presents naringin as a potential target for the treatment of joint degenerative diseases, including OA.
Similar content being viewed by others
Abbreviations
- WT:
-
Wild type
- OA:
-
Osteoarthritis
- RA:
-
Rheumatoid arthritis
- TNF-α:
-
Tumor necrosis factor α
- MMP13:
-
Matrix metallopeptidase 13
- ADAMTS:
-
A disintegrin and metalloproteinase with thrombospondin motifs
- ACLT:
-
Anterior cruciate ligament transaction
References
Kapoor, M., J. Martel-Pelletier, D. Lajeunesse, J.P. Pelletier, and H. Fahmi. 2011. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7: 33–42.
Johnson, K., S. Zhu, M.S. Tremblay, J.N. Payette, J. Wang, L.C. Bouchez, S. Meeusen, A. Althage, C.Y. Cho, X. Wu, and P.G. Schultz. 2012. A stem cell-based approach to cartilage repair. Science 336: 717–721.
Zhen, G., C. Wen, X. Jia, Y. Li, J.L. Crane, S.C. Mears, F.B. Askin, F.J. Frassica, W. Chang, J. Yao, J.A. Carrino, A. Cosgarea, D. Artemov, Q. Chen, Z. Zhao, X. Zhou, L. Riley, P. Sponseller, M. Wan, W.W. Lu, and X. Cao. 2013. Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 19: 704–712.
Cao, X., W. Lin, C. Liang, D. Zhang, F. Yang, Y. Zhang, X. Zhang, J. Feng, and C. Chen. 2015. Naringin rescued the TNF-alpha-induced inhibition of osteogenesis of bone marrow-derived mesenchymal stem cells by depressing the activation of NF-small ka. CyrillicB signaling pathway, Immunol Res 62: 357–367.
Golechha, M., V. Sarangal, J. Bhatia, U. Chaudhry, D. Saluja, and D.S. Arya. 2014. Naringin ameliorates pentylenetetrazol-induced seizures and associated oxidative stress, inflammation, and cognitive impairment in rats: possible mechanisms of neuroprotection. Epilepsy Behav 41: 98–102.
Manna, K., U. Das, D. Das, S.B. Kesh, A. Khan, A. Chakraborty, and S. Dey. 2015. Naringin inhibits gamma radiation-induced oxidative DNA damage and inflammation, by modulating p53 and NF-kappaB signaling pathways in murine splenocytes. Free Radic Res 49: 422–439.
Kawaguchi, K., H. Maruyama, R. Hasunuma, and Y. Kumazawa. 2011. Suppression of inflammatory responses after onset of collagen-induced arthritis in mice by oral administration of the Citrus flavanone naringin. Immunopharmacol Immunotoxicol 33: 723–729.
Zhao, Y.P., B. Liu, Q.Y. Tian, J.L. Wei, B. Richbourgh, and C.J. Liu. 2014. Progranulin protects against osteoarthritis through interacting with TNF-alpha and beta-Catenin signalling. Ann Rheum Dis doi: 10.1136/annrheumdis-2014-205779.
Bowles, R.D., B.A. Mata, R.D. Bell, T.K. Mwangi, J.L. Huebner, V.B. Kraus, and L.A. Setton. 2014. In vivo luminescence imaging of NF-kappaB activity and serum cytokine levels predict pain sensitivities in a rodent model of osteoarthritis. Arthritis Rheumatol 66: 637–646.
Li, W., C. Wang, J. Peng, J. Liang, Y. Jin, Q. Liu, Q. Meng, K. Liu, and H. Sun. 2014. Naringin inhibits TNF-alpha induced oxidative stress and inflammatory response in HUVECs via Nox4/NF-kappa B and PI3K/Akt pathways. Curr Pharm Biotechnol 15: 1173–1182.
Chen, W.H., W.C. Lo, W.C. Hsu, H.J. Wei, H.Y. Liu, C.H. Lee, S.Y. Tina Chen, Y.H. Shieh, D.F. Williams, and W.P. Deng. 2014. Synergistic anabolic actions of hyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritis therapy. Biomaterials 35: 9599–9607.
Lorenz, J., and S. Grassel. 2014. Experimental osteoarthritis models in mice. Methods Mol Biol 1194: 401–419.
Koenders, M.I., E. Lubberts, B. Oppers-Walgreen, L. van den Bersselaar, M.M. Helsen, J.K. Kolls, L.A. Joosten, and W.B. van den Berg. 2005. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Arthritis Rheum 52: 975–983.
Gosset, M., F. Berenbaum, S. Thirion, and C. Jacques. 2008. Primary culture and phenotyping of murine chondrocytes. Nat Protoc 3: 1253–1260.
Tang, W., Y. Lu, Q.Y. Tian, Y. Zhang, F.J. Guo, G.Y. Liu, N.M. Syed, Y. Lai, E.A. Lin, L. Kong, J. Su, F. Yin, A.H. Ding, A. Zanin-Zhorov, M.L. Dustin, J. Tao, J. Craft, Z. Yin, J.Q. Feng, S.B. Abramson, X.P. Yu, and C.J. Liu. 2011. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332: 478–484.
Shuang, F., S.X. Hou, J.L. Zhu, Y. Liu, Y. Zhou, C.L. Zhang, and J.G. Tang. 2015. Establishment of a rat model of lumbar facet joint osteoarthritis using intraarticular injection of urinary plasminogen activator. Sci Rep 5: 9828.
Hu, W., W. Zhang, F. Li, F. Guo, and A. Chen. 2014. Bortezomib prevents the expression of MMP-13 and the degradation of collagen type 2 in human chondrocytes. Biochem Biophys Res Commun 452: 526–530.
Emery P., J. Vencovsky, A. Sylwestrzak, P. Leszczynski, W. Porawska, A. Baranauskaite, V. Tseluyko, V.M. Zhdan, B. Stasiuk, R. Milasiene, A.A. Barrera Rodriguez, S.Y. Cheong, and J. Ghil. 2015. A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy. Ann Rheum Dis doi: 10.1136/annrheumdis-2015-207588
Jani M., H. Chinoy, R.B. Warren, C. Em Griffiths, D. Plant, B. Fu, A.W. Morgan, A.G. Wilson, J.D. Isaacs, K.L. Hyrich, and A. Barton. 2015. Clinical utility of random anti-TNF drug level testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis. Arthritis Rheumatol doi: 10.1002/art.39169.
Zhang, D., and Y. Zhou. 2014. The protective effects of Donepezil (DP) against cartilage matrix destruction induced by TNF-alpha. Biochem Biophys Res Commun 454: 115–118.
Buckland, J. 2013. Osteoarthritis: positive feedback between ADAMTS-7 and TNF in OA. Nat Rev Rheumatol 9: 566.
Chan, B.Y., E.S. Fuller, A.K. Russell, S.M. Smith, M.M. Smith, M.T. Jackson, M.A. Cake, R.A. Read, J.F. Bateman, P.N. Sambrook, and C.B. Little. 2011. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage 19: 874–885.
Vasheghani, F., Y. Zhang, Y.H. Li, M. Blati, H. Fahmi, B. Lussier, P. Roughley, D. Lagares, H. Endisha, B. Saffar, D. Lajeunesse, W.K. Marshall, Y.R. Rampersaud, N.N. Mahomed, R. Gandhi, J.P. Pelletier, J. Martel-Pelletier, and M. Kapoor. 2015. PPARgamma deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Ann Rheum Dis 74: 569–578.
Lai, Y., X. Bai, Y. Zhao, Q. Tian, B. Liu, E.A. Lin, Y. Chen, B. Lee, C.T. Appleton, F. Beier, X.P. Yu, and C.J. Liu. 2014. ADAMTS-7 forms a positive feedback loop with TNF-alpha in the pathogenesis of osteoarthritis. Ann Rheum Dis 73: 1575–1584.
Chtourou, Y., B. Aouey, M. Kebieche, and H. Fetoui. 2015. Protective role of naringin against cisplatin induced oxidative stress, inflammatory response and apoptosis in rat striatum via suppressing ROS-mediated NF-kappaB and P53 signaling pathways. Chem Biol Interact 239: 76–86.
Hui W., D.A. Young, A.D. Rowan, X. Xu, T.E. Cawston, and C.J. Proctor. 2014. Oxidative changes and signalling pathways are pivotal in initiating age-related changes in articular cartilage. Ann Rheum Dis doi: 10.1136/annrheumdis-2014-206295.
Lianxu, C., J. Hongti, and Y. Changlong. 2006. NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes. Osteoarthritis Cartilage 14: 367–376.
Saito, T., A. Fukai, A. Mabuchi, T. Ikeda, F. Yano, S. Ohba, N. Nishida, T. Akune, N. Yoshimura, T. Nakagawa, K. Nakamura, K. Tokunaga, U.I. Chung, and H. Kawaguchi. 2010. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 16: 678–686.
Acknowledgments
This research was supported partly by the Natural Science Foundation of Shandong Province (ZR2011CM022 to Ruifeng Li), Foundation of Shandong Province Outstanding Young Scientist Research Award (BS2014YY048 to Yunpeng Zhao), and a scientific research grant from Qilu Hospital of Shandong University (26010175616073 to Yunpeng Zhao).
Conflict of Interest
We herein declare that we have no conflict of interest.
Contributors
All authors made substantial contributions to design, execution, and reporting of the manuscript and approved the final version.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Yunpeng Zhao and Zhong Li contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhao, Y., Li, Z., Wang, W. et al. Naringin Protects Against Cartilage Destruction in Osteoarthritis Through Repression of NF-κB Signaling Pathway. Inflammation 39, 385–392 (2016). https://doi.org/10.1007/s10753-015-0260-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-015-0260-8